COSMOS Pharmaceutical Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.
Valuation data is not available for this company.
The trajectory is moderate and the balance sheet is sturdy. The company scores 13/20 on our value-creation score: creating some value. Analysts lean positive.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202350
64
2023202420252026
All-time high
79
Jan 2025
All-time low
42
Jan 2024
Average rank
59
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
51
48
43
38
Price/Earnings
51
41
27
29
Price/Book
48
43
39
36
Dividend Yield
35
25
18
14
Value (overall)
39
31
23
17
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.